Characterizing sites of metastatic involvement in metastatic clear-cell, papillary, and chromophobe renal cell carcinoma.
Shaan Dudani(William Osler Health System), Daniel Yick Chin Heng(University of Calgary), Camillo Porta(University of Pavia), Aaron R. Hansen(Princess Margaret Cancer Centre), Benoit Beuselinck(Universitair Ziekenhuis Leuven), Connor Wells(Queen Mary University of London), Ravindran Kanesvaran(University of Ioannina), Felice Pasini(Ospedale Civile Di Ivrea), Sumanta K. Pal(City of Hope), Toni K. Choueiri(Harvard University), Chun Loo Gan(University of Calgary), Georg A. Bjarnason(Sunnybrook Health Science Centre), Jae‐Lyun Lee(Ulsan College), Anna Paola Fraccon, Nils Kroeger(Universitätsmedizin Greifswald), Takeshi Yuasa(Japanese Foundation For Cancer Research), Guillermo de Velasco(Dana-Farber Cancer Institute), Christina M. Canil(University of Ottawa), Frede Donskov(Aarhus University Hospital), M. Neil Reaume(The University of Melbourne)
Cited by 2
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k